Monday, November 2, 2026

North Korea’s 9th Party Congress: Key Economic Strategies Revealed for 2026

North Korea held plenary meetings to implement decisions from the 9th Party Congress, focusing on economic development and living standards.

Destroyer Named After Kim Il-sung’s Comrade Highlights North Korea’s Propaganda Strategy

North Korea's new destroyer is named after guerrilla hero Choe Hyon, emphasizing loyalty to Kim Jong Un and revolutionary legacy.

Kolmar BNH Wins Global HACCP at Two Plants: Raising Food Safety Standards to a Global Level

Kolmar BNH becomes the first health supplement ODM to achieve Global HACCP certification, enhancing food safety management standards.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Study Identifies Gene Pair Interactions Linked to Increased Autism Risk

Researchers reveal how specific gene pair mutations significantly increase autism risk, emphasizing the need for personalized diagnosis and treatment.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

Seoul St. Mary’s Hospital Reaches 20,000 Robotic Surgeries, Marking New Clinical Milestone

Seoul St. Mary's Hospital celebrates 20,000 robotic surgeries, enhancing patient care with advanced single-port techniques for various conditions.

Samsung Biologics Named Dow Jones Best-in-Class World Index for Fifth Straight Year

Samsung Biologics has been recognized in the Dow Jones Best-in-Class World Index for five consecutive years, showcasing its ESG achievements.

Hugel Broadens Collaboration With Korean Clinicians Through Regional Academic Events

Hugel is enhancing its presence in the Korean aesthetics market through academic programs and expanding into Indonesia with training events.

JPI Healthcare Expands From X-Ray Components Into AI-Based Digital Imaging Solutions

JPI Healthcare evolves into an AI-driven imaging platform, enhancing X-ray technology and expanding into tailored medical solutions.

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

GF Fermentech Showcases Synthetic Biology CDMO Platform at SynBioBeta 2026

GF Fermentech showcased its CDMO platform at SynBioBeta 2026, emphasizing rapid commercialization and advanced production technologies.

Humedix Seeks Domestic Approval for PN-HA Composite Filler Valpien

Huons Group's Humedix is set to launch Valpien, a novel composite filler, improving wrinkle treatment with less pain and effective results.

JLK Secures Brazil Regulatory Clearance as It Expands AI Imaging Push in Latin America

JLK accelerates its expansion into Brazil with AI medical imaging solutions, addressing rising healthcare demands for breast cancer and stroke.

National New Drug Development Project Group Holds 2026 Workshop on Investment Review Strategy

The National New Drug Development Project Group held a workshop to discuss drug development trends and investment strategies for future projects.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Large-Scale Real-World Study Supports Zacubo’s Efficacy and Safety in GERD Treatment

A study shows Onconic Therapeutics' Zacubo significantly improves GERD symptoms in patients unresponsive to existing treatments.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.